Literature DB >> 25630038

DDR1 may play a key role in destruction of the blood-brain barrier after cerebral ischemia-reperfusion.

Mingxia Zhu1, Dong Xing1, Zhihong Lu1, Yanhong Fan2, Wugang Hou1, Hailong Dong1, Lize Xiong3, Hui Dong4.   

Abstract

Discoidin domain receptor 1 (DDR1) has been shown to mediate matrix metalloproteinase-9 (MMP-9) secretions and degrade all extracellular matrix compounds in mammalian tumor cells. We hypothesized that DDR1 expression will be elevated and the blood-brain barrier (BBB) will be damaged after focal cerebral ischemia in rats. Inhibiting DDR1 expression can alleviate BBB disruption and cerebral ischemic damage via down-regulation of MMP-9 expression and activity. To test our hypothesis, we injected specific DDR1 siRNA into ipsilateral ischemic lateral ventricles in a focal ischemic model. Our results showed that phospho-DDR1 expression increased after ischemia/reperfusion (I/R) injury (p < 0.01). Inactivation of DDR1 by specific siRNA caused a decrease in phospho-DDR1 and MMP-9 expression in the ischemic cortex, reduced stroke-induced infarct volume, and alleviated BBB disruption in rat brain following I/R injury (p < 0.01). Our results suggested that DDR1-siRNA attenuates phospho-DDR1 and MMP-9 upregulation, which was followed by a reduction in infarction and BBB disruption in the ischemic brain after I/R injury. DDR1 may represent a molecular target for the prevention of BBB disruption after cerebral I/R injury.
Copyright © 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Discoidin domain receptor 1; MCAO; Matrix metalloproteinase; Rats

Mesh:

Substances:

Year:  2015        PMID: 25630038     DOI: 10.1016/j.neures.2015.01.004

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  5 in total

1.  TRPV1 receptor-mediated expression of Toll-like receptors 2 and 4 following permanent middle cerebral artery occlusion in rats.

Authors:  Elham Hakimizadeh; Ali Shamsizadeh; Ali Roohbakhsh; Mohammad Kazemi Arababadi; Mohammad Reza Hajizadeh; Mehdi Shariati; Iman Fatemi; Amir Moghadam-Ahmadi; Gholamreza Bazmandegan; Hossein Rezazadeh; Mohammad Allahtavakoli
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

2.  Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia-reperfusion in rats.

Authors:  Ping Yang; Ye-Mei Tian; Wen-Xiang Deng; Xiong Cai; Wang-Hua Liu; Liang Li; Hui-Yong Huang
Journal:  Exp Ther Med       Date:  2019-08-13       Impact factor: 2.447

3.  CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease.

Authors:  Alan J Fowler; Jaeil Ahn; Michaeline Hebron; Timothy Chiu; Reem Ayoub; Sanjana Mulki; Habtom Ressom; Yasar Torres-Yaghi; Barbara Wilmarth; Fernando L Pagan; Charbel Moussa
Journal:  Neurol Genet       Date:  2021-11-12

4.  Nilotinib modulates LPS-induced cognitive impairment and neuroinflammatory responses by regulating P38/STAT3 signaling.

Authors:  Jieun Kim; Hyun-Ju Lee; Jin-Hee Park; Byung-Yoon Cha; Hyang-Sook Hoe
Journal:  J Neuroinflammation       Date:  2022-07-15       Impact factor: 9.587

5.  Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.

Authors:  Alan J Fowler; Michaeline Hebron; Kaluvu Balaraman; Wangke Shi; Alexander A Missner; Jonathan D Greenzaid; Timothy L Chiu; Clementina Ullman; Ethan Weatherdon; Val Duka; Yasar Torres-Yaghi; Fernando L Pagan; Xiaoguang Liu; Habtom Ressom; Jaeil Ahn; Christian Wolf; Charbel Moussa
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.